Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joe Ensor

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Breast Cancer Research and Treatment|April 16, 2021
ANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancerEmre Koca, Polly Ann Niravath, Joe Ensor, et al.
Journal for Immunotherapy of Cancer|September 22, 2025
Molecular response cutoffs and ctDNA collection timepoints influence on interpretation of associations between early changes in ctDNA and overall survival in patients treated with anti-PD(L)1 and/or chemotherapyHillary S Andrews, Nevine Zariffa, Katherine K Nishimura, et al.
Radiology. Artificial Intelligence|December 11, 2023
A Deep Learning Decision Support Tool to Improve Risk Stratification and Reduce Unnecessary Biopsies in BI-RADS 4 MammogramsChika F Ezeana, Tiancheng He, Tejal A Patel, et al.
Science Translational Medicine|December 15, 2021
A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancerAndrew W Chung, Kartik Anand, Ann C Anselme, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2022
A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast CancerKai Sun, Yitian Xu, Licheng Zhang, et al.
Journal of the National Cancer Institute|June 25, 2014
Effects of obesity on transcriptomic changes and cancer hallmarks in estrogen receptor-positive breast cancerEnrique Fuentes-Mattei, Guermarie Velazquez-Torres, Liem Phan, et al.
JAMA Oncology|August 7, 2015
Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical TrialSimona F Shaitelman, Pamela J Schlembach, Isidora Arzu, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Breast Cancer Research and Treatment|April 16, 2021
ANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancerEmre Koca, Polly Ann Niravath, Joe Ensor, et al.
Journal for Immunotherapy of Cancer|September 22, 2025
Molecular response cutoffs and ctDNA collection timepoints influence on interpretation of associations between early changes in ctDNA and overall survival in patients treated with anti-PD(L)1 and/or chemotherapyHillary S Andrews, Nevine Zariffa, Katherine K Nishimura, et al.
Radiology. Artificial Intelligence|December 11, 2023
A Deep Learning Decision Support Tool to Improve Risk Stratification and Reduce Unnecessary Biopsies in BI-RADS 4 MammogramsChika F Ezeana, Tiancheng He, Tejal A Patel, et al.
Science Translational Medicine|December 15, 2021
A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancerAndrew W Chung, Kartik Anand, Ann C Anselme, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2022
A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast CancerKai Sun, Yitian Xu, Licheng Zhang, et al.
Journal of the National Cancer Institute|June 25, 2014
Effects of obesity on transcriptomic changes and cancer hallmarks in estrogen receptor-positive breast cancerEnrique Fuentes-Mattei, Guermarie Velazquez-Torres, Liem Phan, et al.
JAMA Oncology|August 7, 2015
Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical TrialSimona F Shaitelman, Pamela J Schlembach, Isidora Arzu, et al.
Pageof 8